Li, Zhiguo, et al. “Statins in Hepatitis B or C Patients Is Associated With Reduced Hepatocellular Carcinoma Risk: A Systematic Review and Meta-Analysis”. Turkish Journal of Gastroenterology, vol. 33, no. 2, Jan. 2022, pp. 136-44, doi:10.5152/tjg.2020.19656.